| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |